Medicare Enrolled
Dr. Ashwani Agarwal, M.D.
Medical Oncology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agarwal? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Agarwal
Dr. Ashwani Agarwal is a medical oncology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Agarwal performed 128,584 Medicare services across 2,171 unique beneficiaries.
Between the years covered by Open Payments, Dr. Agarwal received a total of $287,998 from 110 pharmaceutical and/or device companies across 1339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Agarwal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 5% volume in TX$ $287,998 industry payments
Medicare Practice Summary
Medicare Utilization ↗128,584
Medicare services
Top 5% in TX for medical oncology
2,171
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,768 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 45,800 | $0 | $2 |
| Filgrastim injection (Zarxio) for white blood cells | 33,140 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 9,800 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 8,400 | $0 | $5 |
| Paclitaxel chemotherapy injection | 8,188 | $0 | $8 |
| Darbepoetin injection (Aranesp) for anemia | 6,440 | $2 | $20 |
| Denosumab injection (Prolia/Xgeva) | 6,000 | $18 | $65 |
| Dexamethasone injection (steroid) | 1,870 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 1,750 | $5 | $28 |
| Injection, granisetron hydrochloride, 100 mcg | 1,590 | $0 | $24 |
| Office visit, established patient (30-39 min) | 899 | $89 | $368 |
| Complete blood count (CBC) with differential | 520 | $7 | $36 |
| Blood draw (venipuncture) | 497 | $8 | $20 |
| Drug injection, under skin or into muscle | 385 | $10 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 377 | $22 | $157 |
| Anti-nausea injection (Aloxi/palonosetron) | 360 | $1 | $114 |
| Injection, zoledronic acid, 1 mg | 354 | $7 | $431 |
| Administration of chemotherapy into vein, 1 hour or less | 308 | $99 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 306 | $46 | $313 |
| Injection, carboplatin, 50 mg | 150 | $2 | $300 |
| Comprehensive metabolic blood panel | 135 | $10 | $64 |
| Ferritin level test (iron stores) | 123 | $13 | $60 |
| Iron level test | 122 | $6 | $27 |
| Iron binding capacity test | 122 | $9 | $35 |
| New patient office visit (45-59 min) | 107 | $116 | $565 |
| Injection of additional new drug or substance into vein | 99 | $12 | $108 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 96 | $15 | $100 |
| Administration of chemotherapy into vein, each additional hour | 91 | $21 | $161 |
| Injection, diphenhydramine hcl, up to 50 mg | 87 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 76 | $50 | $344 |
| Unclassified drugs | 52 | $1 | $8 |
| Office visit, established patient (20-29 min) | 45 | $68 | $250 |
| Microscopic examination for white blood cells with manual cell count | 40 | $3 | $22 |
| Complete blood count (CBC), automated | 40 | $6 | $34 |
| Infusion into a vein for hydration, each additional hour | 32 | $10 | $75 |
| Infusion, normal saline solution , 1000 cc | 31 | $2 | $19 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 28 | $1,187 | $4,802 |
| Red blood count, automated test | 23 | $4 | $23 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 23 | $91 | $657 |
| Infusion into a vein for hydration, 31-60 minutes | 22 | $25 | $256 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 21 | $1 | $19 |
| Reticulated (young) platelet measurement | 18 | $35 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $69 | $231 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
97.1% medium
2.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$287,998
Total received (2018-2024)
Avg $41,143/year across 7 years
Top 7% in TX for medical oncology
110
Companies
1,339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$178,265 (61.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$92,049 (32.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,683 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$18,453
2023$36,027
2022$46,888
2021$27,199
2020$47,980
2019$80,329
2018$31,122
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Rigel Pharmaceuticals, Inc.
$75,158
AstraZeneca Pharmaceuticals LP
$37,369
Dova Pharmaceuticals
$16,351
Seagen Inc.
$12,667
PFIZER INC.
$9,768
Janssen Biotech, Inc.
$8,856
Regeneron Healthcare Solutions, Inc.
$8,422
TESARO, Inc.
$7,851
Janssen Scientific Affairs, LLC
$7,615
Epizyme, Inc.,
$7,414
Amgen Inc.
$7,307
GENZYME CORPORATION
$6,355
Kite Pharma, Inc.
$4,989
Seattle Genetics, Inc.
$4,871
Teva Pharmaceuticals USA, Inc.
$4,521
Exelixis Inc.
$4,394
Ipsen Biopharmaceuticals, Inc
$4,214
ARRAY BIOPHARMA INC
$4,036
GlaxoSmithKline, LLC.
$4,004
Bayer HealthCare Pharmaceuticals Inc.
$3,875
Bayer Healthcare Pharmaceuticals Inc.
$3,562
Merck Sharp & Dohme LLC
$3,439
Shield Therapeutics Inc
$3,282
Pharmacosmos Therapeutics Inc.
$2,859
EISAI INC.
$2,750
Novartis Pharmaceuticals Corporation
$2,324
ChromaCode, Inc
$2,000
Athenex Pharmaceutical Division, LLC
$2,000
TAIHO ONCOLOGY, INC.
$1,951
MorphoSys, US Inc.
$1,751
Daiichi Sankyo Inc.
$1,693
JAZZ PHARMACEUTICALS INC.
$1,473
Genentech USA, Inc.
$1,457
Incyte Corporation
$1,367
Geron Corporation
$1,300
Gilead Sciences, Inc.
$1,207
E.R. Squibb & Sons, L.L.C.
$1,120
CTI BioPharma Corp.
$1,000
Immunomedics, Inc.
$1,000
BeiGene, Ltd.
$975
Astellas Pharma US Inc
$930
MACROGENICS, INC.
$900
EMD Serono, Inc.
$709
Merck Sharp & Dohme Corporation
$494
Eisai Inc.
$402
Pharmacyclics LLC, An AbbVie Company
$401
Takeda Pharmaceuticals U.S.A., Inc.
$311
PharmaEssentia USA Corporation
$298
Puma Biotechnology, Inc.
$296
Celgene Corporation
$291
ADC Therapeutics America, Inc.
$288
Alexion Pharmaceuticals, Inc.
$277
ABBVIE INC.
$220
Adaptive Biotechnologies Corporation
$216
PUMA BIOTECHNOLOGY, INC.
$202
Lilly USA, LLC
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$167
SOBI, INC
$157
Tempus AI, Inc
$143
Coherus Biosciences Inc.
$132
Synergy Pharmaceuticals Inc
$125
AstraZeneca UK Limited
$113
Taiho Oncology, Inc.
$112
Blueprint Medicines Corporation
$110
Karyopharm Therapeutics Inc.
$98
Mirati Therapeutics, Inc.
$96
Siemens Medical Solutions USA, Inc.
$94
TerSera Therapeutics LLC
$92
Deciphera Pharmaceuticals Inc.
$90
Sirtex Medical Inc
$82
G1 Therapeutics, Inc.
$82
Sun Pharmaceutical Industries Inc.
$79
Clovis Oncology, Inc.
$79
Alnylam Pharmaceuticals Inc.
$72
Myovant Sciences Inc.
$71
Apellis Pharmaceuticals, Inc.
$66
Sobi, Inc
$64
Genmab U.S., Inc.
$64
BeiGene USA, Inc.
$58
Immunocore Limited
$55
AVEO Pharmaceuticals, Inc.
$55
AbbVie, Inc.
$46
Secura Bio, Inc.
$41
Jazz Pharmaceuticals Inc.
$40
SERVIER PHARMACEUTICALS LLC
$40
Agios Pharmaceuticals, Inc.
$39
Stemline Therapeutics Inc.
$36
Acrotech Biopharma LLC
$32
Medtronic USA, Inc.
$31
Emmaus Medical, Inc.
$30
GE HealthCare
$28
RECORDATI_RARE_DISEASES_INC.
$21
Fennec Pharmaceuticals, Inc.
$21
ImmunoGen, Inc.
$19
GE HEALTHCARE
$19
Spectrum Pharmaceuticals Inc.
$18
SANOFI-AVENTIS U.S. LLC
$17
Heron Therapeutics, Inc.
$17
Menarini Silicon Biosystems, Inc.
$17
MENARINI SILICON BIOSYSTEMS, INC.
$17
ADAPT PHARMA INC.
$16
MERZ NORTH AMERICA, INC.
$16
Verity Pharmaceuticals Inc.
$15
Novocure Inc.
$15
Iovance Biotherapeutics, Inc.
$15
AMAG Pharmaceuticals, Inc.
$13
Advanced Accelerator Applications
$13
Foundation Medicine, Inc.
$13
Global Blood Therapeutics, Inc.
$12
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 44.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALPROLIX · ALTUVIIIO · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COPIKTRA · COSELA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · GLEEVEC · HEMLIBRA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEVZARA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MARGENZA · MEKINIST · MEKTOVI · MONJUVI · MONOFERRIC · Molecular Accessories · Molecular Reagents/Test Kit/Clinical Utilization · NERLYNX · NINLARO · Naloxone · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONUREG · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · OXLUMO · Odomzo · Onivyde · Optune Lua (NovoTTF-200T) · Oral Paclitaxel · Orserdu · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PLUVICTO · PREVNAR 20 · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIVDAK · TUKYSA · Tavalisse · Tecartus · Tecentriq · Tepmetko · Tibsovo · Trelstar · Trodelvy · Trulance · Truqap · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XEOMIN · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · XYNTHA · Xofigo · Xospata · Xtandi · YERVOY · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for medical oncology in TX.
Equivalent to $224 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
81
Per 100K population
3.1
County median income
$74,149
Nearest hospital
METHODIST CHARLTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Agarwal is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (consulting-driven, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Agarwal experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Agarwal performed 45,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agarwal receive payments from pharmaceutical companies?
Yes. Dr. Agarwal received a total of $287,998 from 110 companies across 1,339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agarwal's costs compare to other medical oncologys in Dallas?
Dr. Agarwal's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Dallas
Browse medical oncologys in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in TX
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in TX
Which TX medical oncologys receive the most from drug and device companies.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology